Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2017 1
2022 1
2023 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance.
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, Francis F, Buguzi CC, Moshi R, Garimo I, Lazaro S, Lusasi A, Aaron S, Chacky F, Mohamed A, Njau RJA, Kitau J, Rasmussen C, Bailey JA, Juliano JJ, Warsame M. Ishengoma DS, et al. Among authors: garimo i. Lancet Infect Dis. 2024 Nov;24(11):1225-1233. doi: 10.1016/S1473-3099(24)00362-1. Epub 2024 Aug 16. Lancet Infect Dis. 2024. PMID: 39159633 Free PMC article.
Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.
Lyimo BM, Popkin-Hall ZR, Giesbrecht DJ, Mandara CI, Madebe RA, Bakari C, Pereus D, Seth MD, Ngamba RM, Mbwambo RB, MacInnis B, Mbwambo D, Garimo I, Chacky F, Aaron S, Lusasi A, Molteni F, Njau R, Cunningham JA, Lazaro S, Mohamed A, Juliano JJ, Bailey JA, Ishengoma DS. Lyimo BM, et al. Among authors: garimo i. Front Cell Infect Microbiol. 2022 Jul 13;12:757844. doi: 10.3389/fcimb.2022.757844. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35909968 Free PMC article. Review.
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, Francis F, Buguzi C, Moshi R, Garimo I, Lazaro S, Lusasi A, Aaron S, Chacky F, Mohamed A, Njau RJA, Kitau J, Rasmussen C, Bailey JA, Juliano JJ, Warsame M. Ishengoma DS, et al. Among authors: garimo i. medRxiv [Preprint]. 2024 Feb 1:2024.01.31.24301954. doi: 10.1101/2024.01.31.24301954. medRxiv. 2024. Update in: Lancet Infect Dis. 2024 Nov;24(11):1225-1233. doi: 10.1016/S1473-3099(24)00362-1. PMID: 38352311 Free PMC article. Updated. Preprint.
Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients enrolled at 100 health facilities throughout Tanzania: February to July 2021.
Rogier E, Battle N, Bakari C, Seth MD, Nace D, Herman C, Barakoti A, Madebe RA, Mandara CI, Lyimo BM, Giesbrecht DJ, Popkin-Hall ZR, Francis F, Mbwambo D, Garimo I, Aaron S, Lusasi A, Molteni F, Njau R, Cunningham JA, Lazaro S, Mohamed A, Juliano JJ, Bailey JA, Udhayakumar V, Ishengoma DS. Rogier E, et al. Among authors: garimo i. Sci Rep. 2024 Apr 8;14(1):8158. doi: 10.1038/s41598-024-58455-3. Sci Rep. 2024. PMID: 38589477 Free PMC article.
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, Bakari C, Madebe RA, Seth MD, Mandara CI, Popkin-Hall ZR, Moshi R, Mbwambo RB, Niaré K, MacInnis B, Francis F, Mbwambo D, Garimo I, Chacky F, Aaron S, Lusasi A, Molteni F, Njau RJA, Nhiga SL, Mohamed A, Bailey JA, Ishengoma DS. Juliano JJ, et al. Among authors: garimo i. Lancet Microbe. 2024 Oct;5(10):100920. doi: 10.1016/S2666-5247(24)00160-5. Epub 2024 Aug 16. Lancet Microbe. 2024. PMID: 39159629 Free PMC article.
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania.
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, Bakari C, Madebe RA, Seth MD, Mandara CI, Popkin-Hall ZR, Moshi R, Mbwambo RB, Niaré K, MacInnis B, Francis F, Mbwambo D, Garimo I, Chacky F, Aaron S, Lusasi A, Molteni F, Njau RJA, Lazaro S, Mohamed A, Bailey JA, Ishengoma DS. Juliano JJ, et al. Among authors: garimo i. medRxiv [Preprint]. 2023 Nov 30:2023.11.07.23298207. doi: 10.1101/2023.11.07.23298207. medRxiv. 2023. PMID: 37986920 Free PMC article. Preprint.
Mass screening and treatment on the basis of results of a Plasmodium falciparum-specific rapid diagnostic test did not reduce malaria incidence in Zanzibar.
Cook J, Xu W, Msellem M, Vonk M, Bergström B, Gosling R, Al-Mafazy AW, McElroy P, Molteni F, Abass AK, Garimo I, Ramsan M, Ali A, Mårtensson A, Björkman A. Cook J, et al. Among authors: garimo i. J Infect Dis. 2015 May 1;211(9):1476-83. doi: 10.1093/infdis/jiu655. Epub 2014 Nov 26. J Infect Dis. 2015. PMID: 25429102 Free PMC article.
Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar.
Ali AS, Thawer NG, Khatib B, Amier HH, Shija J, Msellem M, Al-Mafazy AW, Garimo IA, Mkali H, Ramsan MM, Kafuko JM, Paxton LA, Reithinger R, Ngondi JM. Ali AS, et al. Among authors: garimo ia. Malar J. 2017 Aug 14;16(1):332. doi: 10.1186/s12936-017-1982-x. Malar J. 2017. PMID: 28807035 Free PMC article.